| Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. |
2024-04-17 |
| Naobios. (4/15/24). "Press Release: Naobios and Sumagen Sign Exclusive Partnership to Develop HIV Vaccine". Nantes. |
2024-04-15 |
| Asahi Kasei Bioprocess. (4/11/24). "Press Release: Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development". Düsseldorf, Tokyo & New York, NY. |
2024-04-11 |
| Nanoform Finland Oyj. (4/11/24). "Press Release: Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan". Helsinki. |
2024-04-11 |
| Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai. |
2024-04-09 |
| Genmab A/S. (4/3/24). "Press Release: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio". Copenhagen & Seattle, WA. |
2024-04-03 |
| Lonza Group AG. (4/2/24). "Press Release: Wolfgang Wienand, Currently CEO of Swiss CDMO Siegfried Holding AG, Will Become Chief Executive Officer of Lonza in the Summer of 2024". Basel. |
2024-04-02 |
| ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin. |
2024-03-26 |
| Engrail Therapeutics, Inc.. (3/19/24). "Press Release: Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies". San Diego, CA. |
2024-03-19 |
| Idorsia Ltd.. (3/18/24). "Press Release: Idorsia and Viatris Successfully Close the Transaction for the Global Research and Development Collaboration". Allschwil. |
2024-03-18 |
| ERS Genomics Ltd.. (3/13/24). "Press Release: Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Tokyo & Dublin. |
2024-03-13 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (3/11/24). "Press Release: Boehringer Ingelheim and Sosei Heptares Join Forces to Develop First-in-class Treatments Targeting All Symptoms of Schizophrenia". Ingelheim, Tokyo & Cambridge. |
2024-03-11 |
| IZB Martinsried. (3/8/24). "Press Release: Christian Gnam Succeeds Dr. Peter Zobel as New Managing Director of the Biotechnology Innovation and Start-up Center (IZB)". Martinsried. |
2024-03-08 |
| Precisio Biotix Therapeutics, Inc.. (3/1/24). "Press Release: Precisio Biotix Therapeutics Acquires London-headquartered CC Bio, Adding World-class Antibacterial Platform and Top Scientists". Dover, DE. |
2024-03-01 |
| Idorsia Ltd.. (2/28/24). "Press Release: Idorsia and Viatris Enter into a Significant Global Research and Development Collaboration". Allschwil. |
2024-02-28 |
| Royal Philips. (28/2/24). "Press Release: Charlotte Hanneman to Succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)". Amsterdam. |
2024-02-28 |
| Alamar Biosciences, Inc.. (2/26/24). "Press Release: Alamar Biosciences Raises $128 Million in Oversubscribed Series C Financing to Accelerate Commercialization of its Proteomics Platform". Fremont, CA. |
2024-02-26 |
| Stilla Technologies SAS. (2/22/24). "Press Release: Stilla Technologies Closes $26.5M Series C Financing to Accelerate Commercialization of Its Digital PCR Platform – Expands Leadership team". Paris & Boston, MA. |
2024-02-22 |
| Agilent Technologies Inc.. (2/21/24). "Press Release: Agilent CEO Mike McMullen to Retire Agilent CrossLab Group – President Padraig McDonnell Named CEO-Elect". Santa Clara, CA. |
2024-02-21 |
| SAFIA Technologies GmbH. (2/15/24). "Press Release: Sysmex Partec and SAFIA Technologies. Pioneering Mycotoxin Analysis". Görlitz & Berlin. |
2024-02-15 |
| Firefly Bio, Inc.. (2/15/24). "Press Release: Firefly Bio Debuts with $94 Million Series A Financing". South San Francisco, CA. |
2024-02-15 |
| BioAge Labs. (2/13/24). "Press Release: BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics". Richmond, CA. |
2024-02-13 |
| Nuclera Ltd.. (2/7/24). "Press Release: Nuclera Partners with Sharp Life Science Advancing Its Digital Microfluidics Capability". |
2024-02-07 |
| VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY. |
2024-02-07 |
| BioNTech SE. (1/31/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305". Mainz & Shanghai. |
2024-01-31 |
| SGS S.A.. (1/26/24). "Press Release: Géraldine Picaud to Succeed Frankie Ng as Chief Executive Officer". |
2024-01-26 |
| SGS S.A.. (1/26/24). "Press Release: SGS 2023 Full Year Results and Strategic Update". |
2024-01-26 |
| Prism BioLab Co., Ldt.. (1/24/24). "Press Release: Prism BioLab Raises 1.5 Billion Yen in Series C Fundraising to Advance Technologies and Programs Targeting Protein-protein Interactions". Tokyo. |
2024-01-24 |
| Precisio Biotix Therapeutics, Inc.. (1/23/24). "Press Release: Precisio Biotix Therapeutics Expands the US Management Team WIth the Hiring of Dr. Raymond Schuch". Dover, DE. |
2024-01-23 |
| BioNTech SE. (1/22/24). "Press Release: BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer". Mainz & Shanghai. |
2024-01-22 |
| Mirae Asset Capital Life Science. (1/18/24). "Press Release: Mirae Asset Capital Life Science Emerges from Stealth with $50M Fund". Boston, MA & San Francisco, CA. |
2024-01-18 |
| WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai. |
2024-01-11 |
| Enamine Ltd.. (1/11/24). "Press Release: Enamine and SyntheticGestalt to Collaborate on the Creation of AI-based Model to Facilitate Drug Discovery". Tokyo & Kyiv. |
2024-01-11 |
| GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio". |
2024-01-09 |
| Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion". |
2024-01-09 |
| BioNTech SE. (1/9/24). "Press Release: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference". Mainz. |
2024-01-09 |
| Shanghai Argo Biopharmaceutical Co., Ltd.. (1/7/24). "Press Release: Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis". Shanghai. |
2024-01-07 |
| SanReno Therapeutics. (1/5/24). "Press Release: SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease". Shanghai. |
2024-01-05 |
| CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA. |
2024-01-05 |
| Menarini Group. (1/4/24). "Press Release: Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications". Florence & New York, NY. |
2024-01-04 |
| Human Immunology Biosciences, Inc. (HI-Bio). (1/4/24). "Press Release: HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases". South San Francisco, CA. |
2024-01-04 |
| Full-Life Technologies. (1/4/24). "Press Release: Global Radiotherapeutics Company Full-Life Technologies Announces USD $47.3 Million Series B Financing, Prosperity7 Ventures Jointly Leads the Round". Shanghai, Gembloux & Heidelberg. |
2024-01-04 |
| Boehringer Ingelheim. (1/3/24). "Press Release: Boehringer Ingelheim Partners with Ribo to Develop New Treatments for People with Liver Diseases". Ingelheim, Mölndal & Kunshan. |
2024-01-03 |
| Qiagen N.V.. (1/3/24). "Press Release: Qiagen Expands Business in Middle East with New Regional Headquarters and Major Projects". Venlo, Muscat & Ryadh. |
2024-01-03 |
| MediLink Therapeutics (Suzhou) Co., Ltd.. (1/2/24). "Press Release: MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to Develop Next-generation Antibody Drug Conjugate in Oncology". Suzhou. |
2024-01-02 |
| Allorion Therapeutics Inc.. (1/2/24). "Press Release: Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca". Natick, MA. |
2024-01-02 |
| Eli Lilly and Company. (12/27/23). "Press Release: Lilly Completes Acquisition of Point Biopharma". Indianapolis, IN. |
2023-12-27 |
| Bristol Myers Squibb Company. (12/26/23). "Press Release: Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio". Princeton, NJ & San Diego, CA. |
2023-12-26 |
| AstraZeneca plc. (12/26/23). "Press Release: AstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". |
2023-12-26 |
| Gracell Biotechnologies Inc.. (12/26/23). "Press Release: Gracell Biotechnologies to Be Acquired by AstraZeneca, furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". San Diego, CA, Suzhou & Shanghai. |
2023-12-26 |
| Paion AG. (12/22/23). "Press Release: Sale of the Business Operations". Aachen. |
2023-12-22 |
| UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". |
2023-12-21 |
| Agilent Technologies Inc.. (12/20/23). "Press Release: Agilent Makes Strategic Updates to Organizational Structure". Santa Clara, CA. |
2023-12-20 |
| GSK plc. (12/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093". London. |
2023-12-20 |
| Ionis Pharmaceuticals, Inc.. (12/18/23). "Press Release: Ionis Announces European Licensing Agreement with Otsuka for Donidalorsen in Hereditary Angioedema". Carlsbad, CA. |
2023-12-18 |
| Tome Biosciences, Inc.. (12/12/23). "Press Release: Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform". Watertown, MA. |
2023-12-12 |
| Shinobi Therapeutics Inc.. (12/12/23). "Press Release: Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform". San Francisco, CA & Kyoto. |
2023-12-12 |
| Novogene. (12/8/23). "Press Release: Novogene Expands Its European Operations with New Genomics Facility at the IZB in Munich, Germany". Martinsried. |
2023-12-08 |
| Odyssey Therapeutics, Inc.. (12/5/23). "Press Release: Odyssey Therapeutics Announces $101 Million Series C Financing". Boston, MA. |
2023-12-05 |
| IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". |
2023-12-05 |
| Merck KGaA. (12/4/23). "Press Release: Merck Strengthens Oncology Portfolio through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib [Not intended for UK-, US- or Canada-based media]". Darmstadt. |
2023-12-04 |
| Merck KGaA. (11/21/23). "Press Release: Merck Expands Newest Biologics Testing Center in Shanghai". Shanghai. |
2023-11-21 |
| Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". |
2023-11-21 |
| AstraZeneca plc. (11/20/23). "Press Release: AstraZeneca Launches Evinova, a Health-tech Business to Accelerate Innovation across the Life Sciences Sector, the Delivery of Clinical Trials and Better Health Outcomes". |
2023-11-20 |
| Eli Lilly and Company. (11/17/23). "Press Release: Lilly Extends Tender Offer to Acquire Point Biopharma to Dec. 1, 2023". Indianapolis, IN. |
2023-11-17 |
| Gracell Biotechnologies Inc.. (11/16/23). "Press Release: Gracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summit". San Diego, CA, Suzhou & Shanghai. |
2023-11-16 |
| Evolva Holding S.A.. (11/14/23). "Press Release: Evolva and Breko Broaden Partnership by Signing Agreement for the Exclusive Distribution of Veri-te Resveratrol in Germany, Austria, Thailand and Vietnam". Reinach. |
2023-11-14 |
| Eckert & Ziegler AG. (11/14/23). "Press Release: Eckert & Ziegler Establishes German-Chinese Joint Venture with DC Pharma for the Production of Radioisotopes". Berlin. |
2023-11-14 |
| Legend Biotech Corporation. (11/13/23). "Press Release: Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3". Somerset, NJ. |
2023-11-13 |
| AstraZeneca plc. (11/9/23). "Press Release: AstraZeneca Licenses Novel Agent for the Treatment of Cardiometabolic Conditions and Obesity [This press release is intended for investors and business / science media]". |
2023-11-09 |
| Kynexis B.V.. (11/7/23). "Press Release: Kynexis Launched to Advance Precision Therapeutics for Brain Diseases". Naarden. |
2023-11-07 |
| Biotheus Inc.. (11/6/23). "Press Release: Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications". Zhuhai. |
2023-11-06 |
| LimFlow S.A.. (11/1/23). "Press Release: LimFlow Announces Agreement to Be Acquired by Inari Medical". Paris & San José, CA. |
2023-11-01 |
| Shanghai Argo Biopharmaceutical Co., Ltd.. (11/1/23). "Press Release: Argo Biopharma Closed Series A+ Financing of Over 40 Milion US Dollars Led by CS Capital". |
2023-11-01 |
| Burning Rock Biotech Ltd.. (10/31/23). "Press Release: Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics". |
2023-10-31 |
| Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.. |
2023-10-31 |
| Abingworth LLP. (10/30/23). "Press Release: Abingworth Raises $356 Million for New Clinical Co-Development Co-Investment Fund (CCD-CIF)". London & New York, NY. |
2023-10-30 |
| Merck KGaA. (10/30/23). "Press Release: Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate [Not intended for US-, Canada- or UK-based media]". Darmstadt |
2023-10-30 |
| Caris Life Sciences Inc.. (10/24/23). "Press Release: Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics". Irving, TX. |
2023-10-24 |
| OrbiMed Advisors LLC. (10/24/23). "Press Release: OrbiMed Raises $4.3 Billion Across Private Investment Funds". New York, NY. |
2023-10-24 |
| Aiolos Bio, Inc.. (10/24/23). "Press Release: Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody". San Francisco, CA & London. |
2023-10-24 |
| High-Tech Gründerfonds Management GmbH. (10/23/23). "Press Release: FarmInsect Raises Oversubscribed €8m Series A to Commercially Scale Its Insect Farming Technology". Munich. |
2023-10-23 |
| GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London. |
2023-10-20 |
| Merck & Co., Inc.. (10/19/23). "Press Release: Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs". Basking Ridge, NJ & Rahway, NJ. |
2023-10-19 |
| Cresset Biomolecular Discovery Ltd.. (10/18/23). "Press Release: Cresset Targets International Growth with Innovate UK Scaleup Programme". Cambridge. |
2023-10-18 |
| MediLink Therapeutics (Suzhou) Co., Ltd.. (10/12/23). "Press Release: MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech to develop next-generation anti-cancer antibody-drug conjugate". Suzhou. |
2023-10-12 |
| Atomic AI. (10/12/23). "Press Release: Atomic AI Adds Bristol Myers Squibb Veteran Dr. Manjunath Ramarao as Chief Scientific Officer". South San Francisco, CA. |
2023-10-12 |
| Lead Discovery Center GmbH. (10/11/23). "Press Release: LDC and JT Team Up for the Discovery of New Therapies". Dortmund. |
2023-10-11 |
| Eppendorf SE. (10/11/23). "Press Release: Eppendorf Realigns Management Board Structure. Eppendorf SE Returns to a Structure with Only One CEO". Hamburg. |
2023-10-11 |
| Circio Holding ASA. (10/10/23). "Press Release: Circio and Neoregen Biotech Enter Collaboration for Delivery of Novel Circular RNA Therapeutics Using NICT technology". |
2023-10-10 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (10/10/23). "Press Release: Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration". Tokyo & Cambridge. |
2023-10-10 |
| Markes International Ltd.. (10/5/23). "Press Release: Schauenburg Analytics Ltd Announces Appointment of New CEO". |
2023-10-05 |
| Evotec SE. (10/5/23). "Press Release: Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners Launch '65LAB'". Hamburg & Singapore. |
2023-10-05 |
| Precede Biosciences. (10/5/23). "Press Release: Precede Biosciences Emerges from Stealth to Dramatically Impact Precision Medicine with a First-in-Class Liquid Biopsy Platform". Boston, MA. |
2023-10-05 |
| Sandoz Group AG. (10/4/23). "Press Release: Sandoz Enters New Era as Standalone Global Leader and European Champion in Generic and Biosimilar Medicines". Basel. |
2023-10-04 |
| EBD Group. (10/4/23). "Press Release: BIO-Europe Set to Break Records in Munich, Germany". Munich. |
2023-10-04 |
| Eli Lilly and Company. (10/3/23). "Press Release: Lilly to Acquire Point Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies". Indianapolis, IN. |
2023-10-03 |
| Mogrify Ltd.. (10/2/23). "Press Release: Mogrify Extends Series A Financing to $46 Million USD". Cambridge. |
2023-10-02 |
| Boehringer Ingelheim. (10/2/23). "Press Release: Boehringer Ingelheim Partners with Precision Health Research, Singapore to Bring Future Medical Breakthroughs to Patients". Ingelheim & Singapore. |
2023-10-02 |
| CellPhenomics GmbH. (9/29/23). "Press Release: Kyan Technologies, Alentis Therapeutics, and CellPhenomics Join Forces Combining Cutting-edge Optim.AI and PD3D Models to Advance Claudin-1 Expression Research". Singapore, Berlin & Allschwil. |
2023-09-29 |
![[LSA] Life-Sciences-Asia.com - The Asia Life Sciences Web Portal](/images/basics/lsa-life-sciences-asia-portal-logo.svg){kind=logo}
Date![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px](/banner/iito-business-intelligence-20220406-650-200-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
